Pulmonary heart disease, cardiomyopathy, Marfan's syndrome Flashcards

1
Q

Differentiate pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH)

A

Pulmonary hypertension (PH) is defined as mean pulmonary artery pressure >25mmHg. Most frequently this is due to heart failure or lung diseases. Pulmonary arterial hypertension (PAH) is a sub-group of PH caused by narrowing of pulmonary vessels. It occurs in isolation and is very rare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 3 symptoms of pulmonary arterial hypertension (PAH)

A

Dyspnoea Fatigue Weakness Angina Syncope Abdominal distension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 3 signs of pulmonary arterial hypertension (PAH)

A

Left parasternal heave: right heart hypertrophy Loud P2 heart sound Soft pansystolic murmur: tricuspid regurgitation Early diastolic murmur: pulmonary regurgitation Right heart failure: JVP distension, ascites, peripheral oedema, and hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define cardiomyopathies

A

A group of diseases of the myocardium that affect the mechanical or electrical function of the heart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classify the types of cardiomyopathies

A

Hypertrophic cardiomyopathy (HCM) Arrhythmogenic cardiomyopathies (ACs) Dilated cardiomyopathy (DCM) Secondary cardiomyopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name 3 causes of secondary cardiomyopathy

A

Infiltrative: amyloidosis, Gaucher’s disease Storage-related: haemochromatosis Drugs: alcohol (esp dilated), cancer therapy Inflammatory: sarcoidosis Autoimmune: SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define hypertrophic cardiomyopathy

A

A group of inherited conditions that produce variable hypertrophy of the myocardium that frequently involves the interventricular septum asymmetrically. HCM occurs in the absence of alternative cause (e.g. aortic stenosis or HTN).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the inheritance pattern of hypertrophic cardiomyopathy

A

Majority are familial autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the symptoms of hypertrophic cardiomyopathy

A

Symptoms: many asymptomatic Chest pain Dyspnoea Syncope/Pre-syncope: typically with exertion Cardiac arrhythmias Sudden death*: commonest cause of sudden cardiac death in young people (up to 6%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List 3 signs of hypertrophic cardiomyopathy

A

4th heart sound: atrial contraction Jerky carotid pulse: rapid ejection and sudden obstruction in systole Ejection systolic murmur: late in systole Pansystolic murmur: mitral regurgitation Irregular pulse: AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is hypertrophic cardiomyopathy investigated?

A

ECG: LV hypertrophy, ST- and T-wave changes, Q waves Echo*(usually diagnostic): asymmetrical LV hypertrophy of interventricular septum, systolic anterior movement of mitral valve, vigorously contracting LV Genetic analysis: confirm diagnosis and provide prognostic information.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the prevalence of HCM?

A

1 in 500 people Commonest cause of sudden cardiac death in young

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the pathophysiology of hypertrophic cardiomyopathy

A

25% have dynamic left ventricular outflow tract (LVOT) obstruction due to combined effects of hypertrophy, systolic anterior motion of anterior mitral valve leaflet, and rapid ventricular ejection. Abnormal intramural coronary arteries, causes anginal chest pain. Chaotic disorganised LV architecture predisposes to arrhythmias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline the management of hypertrophic cardiomyopathy

A

Treatment of symptoms -Chest pain and dyspnoea: Beta-blockers and CCB -Dual chamber pacing -Surgical resection of septal myocardium Prevention of sudden death -Amiodarone -ICD insertion: if 2+ risk factors of sudden cardiac death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name 3 risk factors for sudden cardiac death

A

Massive LV hypertrophy (>30mm) FHx of sudden cardiac death (<50yr) Non-sustained VT on 24h Holter Prior unexplained syncope Abnormal BP response to exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name 5 causes of sudden cardiac death

A

Coronary artery disease -STEMI -Chronic ischaemic heart disease -Following coronary artery bypass -After resuscitation for cardiac arrest -Congenital anomaly of coronary arteries -Coronary arteritis Non-coronary artery disease -Hypertrophic cardiomyopathy -Dilated cardiomyopathy -Arrhythmogenic RV cardiomyopathy -Congenital long QT syndrome -Brugada syndrome -Valvular heart disease +/- infective endocarditis -Cyanotic heart disease: Tetralogy of Fallot, transposition -Acyanotic heart disease: VSD, PDA

17
Q

Define arrhythmogenic cardiomyopathy

A

Uncommon (1 in 1000-5000) inherited condition that predominantly affects the RV with fatty/fibro-fatty replacement of myocytes, leading to dilatation.

18
Q

How can arrhythmogenic cardiomyopathy present?

A

Asymptomatic Symptomatic ventricular arrhythmia Syncope Sudden cardiac death RV failure occurs in late stages

19
Q

How is arrhythmogenic cardiomyopathy treated?

A

Amiodarone or sotalol ICD Cardiac transplant

20
Q

Define dilated cardiomyopathy

A

Dilatation of ventricles with systolic dysfunction, despite preserved wall thickness. Rare: 7-12 in 100,000 Seen more commonly with alcoholics

21
Q

Describe the presentation of dilated cardiomyopathy

A

Heart failure Cardiac arrhythmias Conduction defects Thromboembolism Sudden death

22
Q

How is dilated cardiomyopathy treated?

A

Heart failure treatment If NYHA III/IV: cardiac resync (pacemaker) or ICD

23
Q

What is the inheritance pattern of Marfan’s syndrome?

A

Autosomal dominant

24
Q

Define Marfan’s syndrome

A

An autosomal dominant connective tissue disorder that affects the heart, eyes, and skeleton. Requires 2 of 3 major systems to be involved.

25
Q

What is the cause of Marfan’s syndrome?

A

Mis-sense mutations in gene encoding for fibrillin 1. 2/3 due to familial transmission 1/3 due to sporadic mutations

26
Q

How is a diagnosis of Marfan’s syndrome confirmed?

A

Studying family linkage to causative gene, or Demonstrating mutation in Fibrillin 1 gene

27
Q

Describe the clinical features of Marfan’s syndrome

A

Cardiac: -Aortic aneurysm, dissection, regurgitation -Mitral valve prolapse and regurgitation: systolic murmur Eye: -Lens dislocation, retinal detachment, glaucoma Skeleton: -Pectus excavatum or carinatum -Long arms and legs, arachnodactyly, scoliosis Lungs: -Spontaneous pneumothorax, apical blebs

28
Q

How should Marfan’s syndrome be investigated?

A

Echocardiogram: repeated annually CMR or CT: show entire aorta for monitoring Ambulatory ECG monitoring if symptomatic

29
Q

Outline the non-pharmacological management of Marfan’s syndrome

A

Genetic counselling Psychological support: chronic inheritable disease Advise to avoid over-exertion: fatal aortic dissection Avoid weightlifting, scuba diving, gymnastics

30
Q

Outline the medical management of Marfan’s syndrome

A

Beta-blockers: slows aortic dilatation ACEi: slows aortic dilatation

31
Q

What is the surgical management of Marfan’s syndrome?

A

Aortic root graft replacement*